The Effect of Botulinum Toxin Injection After Hemorrhoidectomy in Pain Control.

NCT ID: NCT05891314

Last Updated: 2023-06-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-12-01

Study Completion Date

2023-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hemorrhoids are a common disease in the general population. Its prevalence is estimated to be 5-36 % and more prevalent in western countries . Half of people older than 50 years of age will suffer from hemorrhoids in a period of their life, of which only 5-10% will require surgical intervention while most of the remainders become asymptomatic and improved with the conservative treatment.

Conservative treatment in the form of diet modification as well as some medical treatment, is usually effective. On the other hand, a few patients require surgical intervention. Surgery is indicated for those not responding to conservative management, those with grade III, and grade IV hemorrhoids.

Surgical treatment is the only curative method for hemorrhoidal disease and indicated for advanced and complicated disease. The most radical operations with the best results are the Milligan-Morgan and Ferguson hemorrhoidectomy .

However, the major concern of hemorrhoidectomy is the post-operative pain that occurs in 20-40 % of patients and it is considered the main cause of refusing surgery. The cause of postoperative pain is multifactorial, including the type of anesthesia , hemorrhoidectomy technique. and spasm of the internal anal sphincter (IAS) that becomes exposed after hemorrhoidectomy. The spasm of the IAS is considered the target to relieve pain post operatively. Lateral internal sphincterotomy (LIS) is widely used as an adjunct to relieve pain post hemorrhoidectomy as it release the spasm of the sphincter and subsequently relieve pain. However, this procedure is not accepted by many surgeons due to its recorded complications as bleeding and mild degree of fecal incontinence, so its role following hemorrhoidectomy is still controversial.

On the other hand, the spasm of the anal sphincter can be abolished by injection of the botulinum toxin which acts on the acetylcholine receptor and consequently temporary muscle paralysis occurs that is followed by decreased pain and wound healing.

Our hypothesis is botulinum toxin relaxes the internal sphincter, so prevent its spasm and so reducing the pain and promoting wound healing more rapidly.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

many procedures have been described to decrease the pain post hemorridectomy. Internal sphincterotomy Botox Injection giving strong analgesics

We aim to evaluate the efficacy of Botox and internal sphincterotomy in pain relief after hemorridectomy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Haemorriodectomy Anal Sphincterotomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Botox injection post hemorridectomy

after piles excision this group will be subjected to botox injection in the internal sphincter

Group Type ACTIVE_COMPARATOR

Botox Injectable Product

Intervention Type PROCEDURE

one group will have botox injection in the internal sphincter

Internal sphincterotomy

Intervention Type PROCEDURE

this group will have internal sphincterotomy

Hemorridectomy alone

Just hemorridectomy without botox injection(control group)

Group Type NO_INTERVENTION

No interventions assigned to this group

Hemorridectomy plus internal sphincterotomy

after piles excision patients will undergo internal sphincterotomy

Group Type ACTIVE_COMPARATOR

Botox Injectable Product

Intervention Type PROCEDURE

one group will have botox injection in the internal sphincter

Internal sphincterotomy

Intervention Type PROCEDURE

this group will have internal sphincterotomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Botox Injectable Product

one group will have botox injection in the internal sphincter

Intervention Type PROCEDURE

Internal sphincterotomy

this group will have internal sphincterotomy

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Botulonium toxin injection lateral internal sphincterotomy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Both sexes,
* aged between 18 and 70 years old.
* Grade III and IV hemorrhoids.
* Those with failed conservative treatment.

Exclusion Criteria

* surgically unfit patients due to multiple comorbidities,
* patients who need emergency operation for complicated hemorrhoids,
* patients with partial rectal prolapse
* patients with rectal varices due to portal hypertension
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mansoura University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmad Sakr

consultant and lecturer of general surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ahmad

Al Mansurah, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5678

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study of Pain Control in Hemorrhoidectomy
NCT00890721 COMPLETED PHASE3
Complex Treatment of a Chronic Anal Fissure
NCT03855046 RECRUITING PHASE4